Enveric Biosciences, Inc. (ENVB)

NASDAQ: ENVB · Real-Time Price · USD

5.32

+0.22 (4.31%)

At close: Apr 28, 2026, 4:00 PM EDT

5.19

-0.13 (-2.44%)

After-hours: Apr 28, 2026, 7:58 PM EDT

Enveric Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Selling, General & Admin	5.79	6.45	8.85	11.73	19.88	Upgrade
Research & Development	2.78	2.84	7.25	7.91	4.76	Upgrade
Operating Expenses	8.77	9.63	16.45	19.96	25.29	Upgrade
Operating Income	-8.77	-9.63	-16.45	-19.96	-25.29	Upgrade
Interest Expense	-0	-	-	-0.01	-0.01	Upgrade
Interest & Investment Income	-	0	0	-	-	Upgrade
Other Non Operating Income (Expenses)	0	0.07	-0.82	7.46	8.2	Upgrade
EBT Excluding Unusual Items	-8.77	-9.57	-17.26	-12.5	-17.1	Upgrade
Merger & Restructuring Charges	-	-	-	-	-0.65	Upgrade
Impairment of Goodwill	-	-	-	-1.49	-8.23	Upgrade
Asset Writedown	-	-	-	-5.97	-30.45	Upgrade
Pretax Income	-8.77	-9.57	-17.26	-19.96	-56.43	Upgrade
Income Tax Expense	-	0.01	0.03	-1.49	-7.45	Upgrade
Net Income	-8.77	-9.57	-17.29	-18.47	-48.98	Upgrade
Preferred Dividends & Other Adjustments	3.36	-	0.17	0.33	-	Upgrade
Net Income to Common	-12.13	-9.57	-17.46	-18.8	-48.98	Upgrade
Shares Outstanding (Basic)	0	0	0	-	-	Upgrade
Shares Outstanding (Diluted)	0	0	0	-	-	Upgrade
Shares Change (YoY)	698.70%	249.38%	-	-	-	Upgrade
EPS (Basic)	-36.24	-228.48	-1455.50	-	-	Upgrade
EPS (Diluted)	-36.24	-228.48	-1455.50	-	-	Upgrade
Free Cash Flow	-8.14	-7.73	-14.1	-17.73	-11.65	Upgrade
Free Cash Flow Per Share	-24.32	-184.36	-1175.46	-	-	Upgrade
EBITDA	-8.57	-9.29	-16.1	-19.63	-24.64	Upgrade
D&A For EBITDA	0.2	0.34	0.34	0.33	0.66	Upgrade
EBIT	-8.77	-9.63	-16.45	-19.96	-25.29	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.